FDA Investigator Helen R Bester
Helen R Bester has conducted inspections on 84 sites in 2 countries as of 28 Jul 2004. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
84
Last Inspection Date:
28 Jul 2004
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Canada
FDA Investigators that have inspected at least one site in common with Helen R Bester:
Aaron P Wozniak,
Amanda L Evanco,
Amy A Johnson,
Amy H Ruble,
Anita R Michael,
Ann Marie Montemurro,
Annette A Ragosta,
Annette Melendez,
April R Bowen,
Arie C Menachem,
Babatunde D Babalola,
Barbara D Wright,
Barbara T Carmichael,
Bonita S Chester,
Brandon L Mariner,
Brandy D Brown,
Brentley S Collins,
Brian A Graves,
Burnell M Henry,
Calvin Foulks,
Cara M Minelli,
Carl E Lovrich,
Carol F Robinson,
Carol J Blackwood,
Chateryl K Washington,
Cheryl D Barton,
Christina H Owens,
Christopher J Adams,
Claudele S Razo,
Claudette D Brooks,
Cody D Rickman,
Cordelia J Brammer,
Cynthia Jim, CSO,
Dawn M Braswell,
Debra J Tucker,
Dellarese L Herbert,
Derek C Price,
Devaughn Edwards,
Dionne D Arline,
Doretha M Tonkins,
Doretha M Wilson,
Douglas F Frazier,
Dr. Gang Wang, PhD,
Edecia A Richards,
Edward Deberry,
Eileen J Bannerman,
Eliezar Ramos,
Ernest H Blackwood,
Esra Toussaint,
Eural E Porter,
Fabian Nchaparro Rodriguez,
Fulton A Varner,
Gail L Katz,
Gary E Coleman, Jr, REHS,
Gene D Arcy,
Helen B Ricalde,
Holly M Scott,
Hristu B Chepa,
Ibad U Khan,
Inga M Warr,
Jackie M Douglas,
Jacqueline Mdiaz Albertini,
James C Maclaughlin,
Jana L Caylor,
Janet B Gray,
Jessica Fields,
Joanne Pryzbylik,
Joe A Odom,
Jonathan G Matrisciano,
Julie D Bringger,
Karen A Coleman,
Kelley L Clark,
Kenneth L Smalls,
Kimberly Cdelk Brooks,
Kip J Hanks,
Latonya T Jiggetts,
Laurel A Beer,
LCDR Debra Emerson,
Leena Thomas,
Leslie W Gilbert,
Linda Thai,
Lorenzo Jones,
Lori A Holmquist,
Marian A Kainer,
Marion Michaelis,
Mariza M Jafary,
Marla A Cassidy,
Mary A Millner,
Mary Alice Papadimitriou,
Megan K Robinson,
Melanie M Walker,
Melanie W Pishnery,
Miaja Umaedi,
Michael R Goga,
Michelle D Haamid,
Mihaly S Ligmond,
Mizanne E Lewis,
Myla D Chapman,
Myoshi M Francis,
Nancy L Neiger,
Nawab A Siddiqui,
Nicholas M Smith,
Omotunde O Osunsanmi,
Pamela L Velez Vega,
Patricia F Hudson,
Paul A Bonneau,
Paul W Moy,
Paula A Trost,
Paula J Bretz,
Prabhu P Raju,
Randy L Clarida,
Rhonda Alexander,
Richard J Bashay,
Richard L Garcia,
Robert W Fisher,
Ronnie E Jackson,
Rose Ashley,
Russell R Zablan,
Sayeeda Hdabe,
Sharna D Pratt,
Sheryl A Kochman,
Shusheen A Alexander,
Shwnji Susie Lee,
Stardust W Mazzariello,
Stephanie E Hubbard,
Stephanie Harrell,
Stephen D Brown,
Steven D Banks,
Susan M Jackson,
Susan Yu,
Tammara A Stephens,
Thao Le,
Theressa B Smith,
Tracy R Ball,
Trang N Cox,
Valerie Jgrecek Trinh,
Vanessa E Coulter,
Vincent M Williams,
Wella Wang,
Xiomara Copeland
Helen R Bester's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| March, 2002 | EIR | Regenerative Biologics Inc. - EIR, 2002-03-21 |
| April, 2002 | FDA 483 | Artivion, Inc - Form 483, 2002-04-12 |
| April, 2002 | FDA 483 Response | Artivion, Inc - Form 483R, 2002-05-15 |
| April, 2002 | EIR | Artivion, Inc - EIR, 2002-04-12 |
| March, 2002 | FDA 483 Response | Regenerative Biologics Inc. - Form 483R, 2002-04-16 |
| October, 2000 | FDA 483 | American National Red Cross (The) Carolinas Region - Form 483, 2000-07-26 |
| March, 2002 | FDA 483 | Regenerative Biologics Inc. - Form 483, 2002-03-21 |
| January, 2000 | FDA 483 | American Red Cross - Form 483, 2000-01-26 |
| October, 2000 | FDA 483 | The American National Red Cross South Carolina Region - Form 483, 2000-08-18 |
| October, 2002 | FDA 483 Response | Walter L. Shepeard Community Blood Center, Inc. - Form 483R, 2002-11-12 |
| October, 2002 | FDA 483 | Walter L. Shepeard Community Blood Center, Inc. - Form 483, 2002-10-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more